Enzymatica publ AB (ENZY) — Strategic Asset Allocation Index
Enzymatica publ AB (ENZY) has a Strategic Asset Allocation Index of 8.6% as of September 2025. Strategic assets (PP&E of Skr11.70 Million plus long-term investments of Skr-) total Skr11.70 Million, measured against net assets of Skr135.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Enzymatica publ AB's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Enzymatica publ AB Strategic Asset Allocation Index (2007–2024)
This chart shows how Enzymatica publ AB's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2024. As of September 2025, the index stands at 8.6%, representing strategic assets of Skr11.70 Million against net assets of Skr135.68 Million SEK. See Enzymatica publ AB (ENZY) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Enzymatica publ AB (2007–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Enzymatica publ AB from 2007 to 2024, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Enzymatica publ AB (ENZY) market capitalisation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 8.2% | Skr14.40 Million | Skr14.40 Million | Skr- | Skr176.37 Million | ▼ -13.4 pp |
| 2023 | 21.5% | Skr16.48 Million | Skr16.48 Million | Skr- | Skr76.61 Million | ▲ +8.5 pp |
| 2022 | 13.0% | Skr16.40 Million | Skr16.40 Million | Skr- | Skr126.29 Million | ▲ +0.9 pp |
| 2021 | 12.1% | Skr15.16 Million | Skr15.16 Million | Skr- | Skr124.97 Million | ▲ +2.5 pp |
| 2020 | 9.6% | Skr10.26 Million | Skr10.26 Million | Skr- | Skr106.65 Million | ▲ +2.1 pp |
| 2019 | 7.5% | Skr8.95 Million | Skr6.78 Million | Skr2.17 Million | Skr119.20 Million | ▲ +3.9 pp |
| 2018 | 3.6% | Skr5.77 Million | Skr4.54 Million | Skr1.24 Million | Skr159.66 Million | ▼ -0.8 pp |
| 2017 | 4.4% | Skr4.89 Million | Skr4.87 Million | Skr23.00K | Skr110.70 Million | ▲ +1.3 pp |
| 2016 | 3.1% | Skr4.40 Million | Skr4.38 Million | Skr23.00K | Skr142.04 Million | ▲ +1.8 pp |
| 2015 | 1.3% | Skr276.00K | Skr276.00K | Skr- | Skr21.98 Million | ▲ +0.8 pp |
| 2014 | 0.5% | Skr303.00K | Skr303.00K | Skr- | Skr62.42 Million | ▼ -0.9 pp |
| 2013 | 1.4% | Skr220.00K | Skr220.00K | Skr- | Skr15.73 Million | ▲ +1.3 pp |
| 2012 | 0.1% | Skr17.00K | Skr17.00K | Skr- | Skr14.06 Million | ▼ -0.6 pp |
| 2011 | 0.8% | Skr25.00K | Skr25.00K | Skr- | Skr3.31 Million | ▲ +0.4 pp |
| 2010 | 0.3% | Skr15.00K | Skr15.00K | Skr- | Skr4.40 Million | ▼ -20.8 pp |
| 2007 | 21.2% | Skr11.00K | Skr11.00K | Skr- | Skr52.00K | — |